BRPI0920764A2 - composto com estrutura de carbono spiro quiral, método de preparação do mesmo, e composição farmacêutica contendo o mesmo - Google Patents

composto com estrutura de carbono spiro quiral, método de preparação do mesmo, e composição farmacêutica contendo o mesmo

Info

Publication number
BRPI0920764A2
BRPI0920764A2 BRPI0920764A BRPI0920764A BRPI0920764A2 BR PI0920764 A2 BRPI0920764 A2 BR PI0920764A2 BR PI0920764 A BRPI0920764 A BR PI0920764A BR PI0920764 A BRPI0920764 A BR PI0920764A BR PI0920764 A2 BRPI0920764 A2 BR PI0920764A2
Authority
BR
Brazil
Prior art keywords
preparation
pharmaceutical composition
composition containing
same
carbon structure
Prior art date
Application number
BRPI0920764A
Other languages
English (en)
Inventor
Chan-Soo Shin
Eun-O Kim
heon-joong Kang
Jae-Hwan Lee
Jeong-Ah Kim
Jeong-Ho Hong
Jun-Young Hong
Jung-Rae Rho
Sang-Mi Oh
Seung-Bum Park
Original Assignee
Snu R&Db Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Snu R&Db Foundation filed Critical Snu R&Db Foundation
Publication of BRPI0920764A2 publication Critical patent/BRPI0920764A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
BRPI0920764A 2008-10-31 2009-10-30 composto com estrutura de carbono spiro quiral, método de preparação do mesmo, e composição farmacêutica contendo o mesmo BRPI0920764A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20080107821 2008-10-31
KR1020090104124A KR101149878B1 (ko) 2008-10-31 2009-10-30 스파이로키랄 탄소 골격을 갖는 신규한 화합물, 그의 제조방법 및 그를 포함하는 약제학적 조성물
PCT/KR2009/006357 WO2010050783A2 (ko) 2008-10-31 2009-10-30 스파이로키랄 탄소 골격을 갖는 신규한 화합물, 그의 제조방법 및 그를 포함하는 약제학적 조성물

Publications (1)

Publication Number Publication Date
BRPI0920764A2 true BRPI0920764A2 (pt) 2015-12-22

Family

ID=42275585

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0920764A BRPI0920764A2 (pt) 2008-10-31 2009-10-30 composto com estrutura de carbono spiro quiral, método de preparação do mesmo, e composição farmacêutica contendo o mesmo

Country Status (11)

Country Link
US (1) US8703813B2 (pt)
EP (1) EP2363400B1 (pt)
JP (1) JP2012507509A (pt)
KR (1) KR101149878B1 (pt)
CN (1) CN102203099B (pt)
AU (1) AU2009310544A1 (pt)
BR (1) BRPI0920764A2 (pt)
CA (1) CA2742364A1 (pt)
ES (1) ES2423196T3 (pt)
RU (1) RU2492173C2 (pt)
WO (1) WO2010050783A2 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130274212A1 (en) * 2010-09-07 2013-10-17 Snu R&Db Foundation Sesterterpene Compounds and Use Thereof
KR101647507B1 (ko) 2014-10-20 2016-08-10 건국대학교 글로컬산학협력단 정전용량 기반의 혈관삽입형 바이오센서를 이용한 심혈관 질환 진단 데이터 획득 시스템 및 방법
CN104873499B (zh) * 2015-06-11 2017-10-17 中国医学科学院医药生物技术研究所 一种上调Runx2 转录活性的化合物在防治骨质疏松中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5328929A (en) * 1993-07-02 1994-07-12 Arizona Board Of Regents Isolation and structure of spongistatin 2, spongistatin 3, spongistatin 4 and spongistatin 6
JP3331028B2 (ja) * 1993-11-16 2002-10-07 第一製薬株式会社 スピロ化合物及びその製法
JP2003514033A (ja) * 1999-11-15 2003-04-15 パーカー ヒューズ インスティテュート 癌治療用のホルボキサゾール誘導体
JP2005035895A (ja) * 2003-07-15 2005-02-10 Institute Of Physical & Chemical Research 高カルシウム血症および骨疾患治療剤
US7485631B2 (en) * 2005-04-21 2009-02-03 The Trustees Of The University Of Pennsylvania Phorboxazole compounds and methods of their preparation
JP3988833B2 (ja) * 2006-12-01 2007-10-10 日東電工株式会社 新規セスキテルペン系化合物、その製造方法及び組成物

Also Published As

Publication number Publication date
AU2009310544A1 (en) 2010-05-06
CN102203099B (zh) 2014-03-12
EP2363400B1 (en) 2013-06-12
KR101149878B1 (ko) 2012-05-24
KR20100048934A (ko) 2010-05-11
EP2363400A2 (en) 2011-09-07
US20110218240A1 (en) 2011-09-08
WO2010050783A2 (ko) 2010-05-06
WO2010050783A3 (ko) 2010-09-10
RU2011121877A (ru) 2012-12-10
ES2423196T3 (es) 2013-09-18
JP2012507509A (ja) 2012-03-29
US8703813B2 (en) 2014-04-22
EP2363400A4 (en) 2012-04-18
RU2492173C2 (ru) 2013-09-10
CN102203099A (zh) 2011-09-28
CA2742364A1 (en) 2010-05-06

Similar Documents

Publication Publication Date Title
DK2282994T3 (da) 3-aminocarbazolforbindelse, farmaceutisk sammensætning indeholdende forbindelsen samt fremstillingsmetode derfor
BRPI0920263A2 (pt) composto, uso do composto, composição, e, método
BRPI0821115A2 (pt) Composto derivado de aminotriazol, medicamento, composição farmacêutica e uso do composto
BRPI0919942A2 (pt) Composto, composição farmacêutica, e, uso de um composto
BRPI0907562A2 (pt) composto, composição farmacêutica, e, uso de um composto
BRPI0921375A2 (pt) composto, composição farmacêutica, e, uso de um composto
BRPI0917579A2 (pt) composto, composição farmacêutica, métodos, e, uso de um composto
BRPI0906962A2 (pt) Composto, e, composição farmacêutica
BRPI0906556A2 (pt) Composto, e, composição farmacêutica
BR112012022878A2 (pt) composto, composição farmacêutica, uso do compostos e método de tratamento
BRPI0917001A2 (pt) composto, composição farmacêutica, e, uso de um composto ou uma composição farmacêutica
BR112012022879A2 (pt) composto, composição farmacêutica, uso do composto e método de tratamento
BRPI0921879A2 (pt) composto, composição farmacêutica , e, uso de um composto
BR112012004335A2 (pt) composto, composição farmacêutica, e, uso do composto.
BRPI0913739A2 (pt) Composição líquida, método, e, uso de composição
CL2007002377A1 (es) Compuestos derivados de quinazolina; procedimiento de preparacion; composicion farmaceutica; y su uso como anticancerigeno.
BRPI0809661A2 (pt) Composição farmacêutica estabilizada contendo pregabalina
BRPI0915120A2 (pt) composto derivado de oxima, uso do referido composto e composição farmacêutica
BRPI0917681A2 (pt) Composto, e, composição farmacêutica
BRPI0906937A2 (pt) composto, composição farmacêutica, e, uso de um composto
BRPI0910179A2 (pt) composto de amina, composição farmacêutica e uso do composto de amina
BRPI0915473A2 (pt) composto, composição farmacêutica, e, uso de um composto
BRPI0919165A2 (pt) composição farmacêutica,e, uso de um composto
BRPI0720323A2 (pt) composto, método de tratamento, composição farmacêutica e uso do composto
BRPI0907706A2 (pt) Composto, uso do dito composto e composição farmacéutica compreendendo o dito composto

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.